Humana Q2 2024 Earnings Report
Key Takeaways
Humana reported a solid second quarter with a GAAP EPS of $5.62 and an adjusted EPS of $6.96. The company has revised its full-year GAAP EPS guidance to approximately $12.81 while affirming its Adjusted EPS guidance of approximately $16.00. Humana is raising its 2024 individual Medicare Advantage annual membership growth to approximately 225,000, or 4.2 percent.
Reported 2Q24 EPS of $5.62 on a GAAP basis, and Adjusted EPS of $6.96.
Revised FY 2024 EPS guidance to approximately $12.81 on a GAAP basis, while affirming Adjusted EPS of approximately $16.00.
Affirmed FY 2024 Insurance segment benefit ratio of approximately 90 percent.
Raised 2024 individual Medicare Advantage annual membership growth by 75,000 to approximately 225,000, or 4.2 percent.
Humana
Humana
Humana Revenue by Segment
Forward Guidance
Humana revised its GAAP EPS guidance for the year ending December 31, 2024 (FY 2024) to approximately $12.81 from approximately $13.93, while affirming its Adjusted EPS guidance of approximately $16.00.
Positive Outlook
- Adjusted EPS – FY 2024 projected approximately $16.00
Challenges Ahead
- GAAP approximately $12.81